newsfilter
← Latest News
PR Newswire·

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM Evidence. The full...